Antihypertensive Market : Industry to Witness Fastest Growth by 2023

Antihypertensive is a treatment for hypertension. The increase in blood pressure is also referred to as arterial hypertension because it is measured by blood on the arterial wall in terms of systolic and diastolic blood pressure. Antihypertensive agents relieve complications of stroke and myocardial infarction. Lowering blood pressure can minimize the risk of death from heart attack, ischemic heart disease, dementia and hypertension. Lifestyle changes are a major factor in increasing the number of hypertensive patients. A complete analysis of the global antihypertensive market provides various aspects of market research, including market trends, market drivers, inhibition and opportunity. In-depth sectoral analysis helps you understand market dynamics and helps professionals in decision-making. The Competitive Environment section focuses on key leaders and key growth strategies in the global antihypertensive market.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/436

The global antihypertensive market is driven by increasing global epidemics of hypertension. Changes in lifestyle, eating habits, and increased stress levels can cause an increase in the number of hypertensive patients. The global antihypertensive market is expected to grow steadily over the forecast period due to patent expirations of major antihypertensive agents. The market can face the challenges of increased generic threats and increased competition. The continued increase in pulmonary arterial hypertension and the use of fixed dose combination therapies are expected to lead to future growth in the antihypertensive market. The introduction of new safety and efficacy therapies can accelerate market growth in the near future.

Global Antihypertensives Market by Therapeutics

The global antihypertensives market is segmented by therapeutics into different categories such as Diuretics, Angiotensin receptor blockers (ARBs), Angiotensin converting enzyme (ACE) inhibitors, Beta blockers, Alpha blockers, Calcium channel blockers, Renin inhibitors and Vasodilators. Diuretics hold the largest market share for antihypertensives, as it is the first line of treatment for hypertension recommended by most of the physicians. However, selection and suitability of drug candidate is based on patient’s medical history and current symptoms. Beta blocker, Calcium channel blocker ad ACE inhibitors are also a popular drug class form antihypertensives and used as first line of treatment in some cases.

Global Antihypertensives Market by Geography

Geographically, global antihypertensives market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America and Europe dominates the global antihypertensives market. Europe has high prevalence of hypertension, which is the primary cause of mortality and disability amongst people. Also in US, blood pressure is one of the major factors that has high mortality rate. Asia-Pacific is the lucrative geographic segment for antihypertensive drug manufacturers due to high incidences of cardiovascular diseases, government support and improving healthcare conditions.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/436

Competitive Landscape

Pfizer Inc., Novartis AG, Sanofi S.A., Merck & Co., Boehringer Ingelheim, Lupin Limited, Johnson & Johnson Ltd., Astra Zeneca Plc, Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited, Inc. are some of the key players of global antihypertensives market. Over the past few years, the patent expiration of major brands, namely Revatio, Diovan, Exforge and Avapro has led to high genericization of antihypertensives market. The novel antihypertensive drugs, which are in pipeline research, are expected to partly regain the losses due to patent expiration. These novel therapies include Actos, Macitentan, Riociguat, SPP635, ACT-293987, LCZ696 and others.

High Level Analysis

A comprehensive analysis of the global antihypertensives market provides an overview of the market and its key concerns. The market segmentation section provides a deep-dive analysis of Therapeutics and geography segments, which would be helpful in understanding niche market trends. Market dynamics include market drivers, restraints and opportunities, which would help to simplify and better understand market behavior. Porter’s Five Forces analysis would be helpful to strategists to determine market profitability. Genericization of the drugs has introduced the cheaper versions of original brands and offered the cost effectiveness to the buyers. This factor strengthens the buyer’s power. Patent expiration of blockbuster drugs has offered an opportunity for local players to enter the market, which has also contributed to make the industrial rivalry intense.

KEY BENEFITS

• This report offers the following benefits in particular:
• Comprehensive coverage of global antihypertensives market along with disease overview, market trends, drivers and restraints would provide key insights to market dynamics
• Thorough attention is given to leading company portfolios, pipeline research, new launches and competitive landscape of top players
• Explicit information on current clinical trials and R&D activities would be beneficial to understand the future market trends
• Insightful analysis of different segments helps to recognize and capitalize future opportunities within global antihypertensives market

For More Details on this Report visit @ https://www.alliedmarketresearch.com/antihypertensives-market

KEY DELIVERABLES

The global antihypertensives market is segmented into two major categories such as therapeutics and Geography.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.